• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
How to Save Clinical Labs from Future Pandemic Challenges

How to Save Clinical Labs from Future Pandemic Challenges

by Rachel Muenz | Apr 22, 2022 | Articles, News, Open Content

A recent AMP report offers recommendations to policymakers to prevent problems in future public health emergencies.

CMS Launches Free Medicare Coverage of OTC COVID-19 Rapid Antigen Tests

CMS Launches Free Medicare Coverage of OTC COVID-19 Rapid Antigen Tests

by Glenn S. Demby | Apr 21, 2022 | Articles, CMS-nir, Essential, National Lab Reporter

Starting April 4, Medicare beneficiaries can get eight free tests per month for each month the public health emergency remains in effect.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
FDA Releases Latest List of Authorized At-Home OTC COVID-19 Tests

FDA Releases Latest List of Authorized At-Home OTC COVID-19 Tests

by Rachel Muenz | Apr 1, 2022 | Articles, News, Open Content

With coverage of over-the-counter (OTC) COVID-19 tests set to expand to include those covered by Medicare, the U.S. Food and Drug Administration (FDA) recently released its most up-to-date list of authorized at-home test kits for the SARS-CoV-2 virus that causes...

CMS Proposes Clarified Medicare Coverage “Reasonable and Necessary” Criteria for Breakthrough Devices

by Glenn S. Demby | Sep 17, 2020 | Articles, National Lab Reporter

...

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Medicare Coverage: NGS Testing of Early-Stage Cancer Patients Is Back in Play

Medicare Coverage: NGS Testing of Early-Stage Cancer Patients Is Back in Play

by Glenn S. Demby | Jun 17, 2019 | CMS-nir, Essential, National Lab Reporter, Reimbursement-nir

From - National Intelligence Report
The reimbursement outlook for those who provide next generation sequencing (NGS) testing to early-stage cancer of Medicare patients with…


. . . read more

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries
Next Entries »

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com